Skip to Content
  • Previous Rank
    507
  • Revenues ($M)
    $5,825.0
  • Revenue Percent Change
    9.8%
  • Profits ($M)
    $1,428.0
  • Profits Percent Change
    65.3%
  • Assets ($M)
    $10,777.0
  • Employees
    10,000

Zoetis develops and manufactures animal health medicines and vaccines that aim to help veterinarians, as well as livestock farmers.

Company Info

CEO
Kristin C. Peck
CEO Title
Chief Executive Officer & Director
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
Parsippany, N.J.
Websitehttp://www.zoetis.com
Years on Fortune 500 List1
Employees10,000

Zoetis Rank History

placeholder

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$5,825.09.8%
Profits ($M)$1,428.065.3%
Assets ($M)$10,777.0-
Total Stockholder Equity ($M)$2,185.0-

Profit Ratios

Profit as % of Revenues24.5%
Profits as % of Assets13.3%
Profits as % of Stockholder Equity65.4%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)2.93
EPS % Change (from 2017)67.4%
EPS % Change (5 year annual rate)23.7%
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2018)19.4%
Total Return to Investors (5 year, annualized)22.1%
Total Return to Investors (10 year, annualized)-